David Zarrinpar

David Zarrinpar practices at Southern California Medical Center - Van Nuys in Vannuys, California.

David Zarrinpar's NPI, 1598802803, was assigned on January 30, 2007. David Zarrinpar holds California license A54056.

David Zarrinpar's primary practice is Southern California Medical Center - Van Nuys, at 14550 Haynes Street, Vannuys, CA 91411. The practice phone is (818) 650-6700.

David Zarrinpar's primary practice is Southern California Medical Center - Van Nuys in Vannuys, California. The medical group on file is Serra Medical Group. Dmand AI also links David Zarrinpar to 2 more medical groups and 1 group practice or clinic, each named with a free account. David Zarrinpar's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where David Zarrinpar practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is David Zarrinpar's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. David Zarrinpar is licensed in California.

CMS data shows 19 Medicare services from David Zarrinpar across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $1,927 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw David Zarrinpar in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have diabetes, and 75% have high blood pressure. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Zarrinpar's median patient age at 45, with 62% women.

In 2024, David Zarrinpar wrote 94 Medicare Part D claims for 43 patients. 96% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $63 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for David Zarrinpar for performance year 2024, reported as part of a group. David Zarrinpar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to David Zarrinpar from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $151.